View ValuationNeoCore Technology 将来の成長Future 基準チェック /06現在、 NeoCore Technologyの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Biotechs 収益成長35.1%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesReported Earnings • May 14First quarter 2026 earnings released: NT$0.046 loss per share (vs NT$0.32 loss in 1Q 2025)First quarter 2026 results: NT$0.046 loss per share (improved from NT$0.32 loss in 1Q 2025). Revenue: NT$60.5m (down 13% from 1Q 2025). Net loss: NT$1.82m (loss narrowed 85% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 14Full year 2025 earnings released: NT$1.23 loss per share (vs NT$1.23 loss in FY 2024)Full year 2025 results: NT$1.23 loss per share (improved from NT$1.23 loss in FY 2024). Revenue: NT$61.5m (flat on FY 2024). Net loss: NT$48.1m (flat on FY 2024). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.お知らせ • Mar 05NeoCore Technology Co., Ltd., Annual General Meeting, Jun 24, 2026NeoCore Technology Co., Ltd., Annual General Meeting, Jun 24, 2026. Location: no,9, lu k`o 1st rd., lujhu district, kaohsiung city TaiwanReported Earnings • Nov 15Third quarter 2025 earnings released: NT$0.42 loss per share (vs NT$0.36 loss in 3Q 2024)Third quarter 2025 results: NT$0.42 loss per share (further deteriorated from NT$0.36 loss in 3Q 2024). Revenue: NT$55.2m (up 235% from 3Q 2024). Net loss: NT$16.7m (loss widened 19% from 3Q 2024). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 17Second quarter 2025 earnings released: EPS: NT$0.31 (vs NT$0.39 loss in 2Q 2024)Second quarter 2025 results: EPS: NT$0.31 (up from NT$0.39 loss in 2Q 2024). Revenue: NT$53.7m (up 204% from 2Q 2024). Net income: NT$12.0m (up NT$27.1m from 2Q 2024). Profit margin: 22% (up from net loss in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • May 14First quarter 2025 earnings released: NT$0.31 loss per share (vs NT$0.40 loss in 1Q 2024)First quarter 2025 results: NT$0.31 loss per share (improved from NT$0.40 loss in 1Q 2024). Revenue: NT$69.6m (up 341% from 1Q 2024). Net loss: NT$12.3m (loss narrowed 21% from 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 35% per year, which means it is well ahead of earnings.Reported Earnings • Mar 19Full year 2024 earnings released: NT$1.23 loss per share (vs NT$1.87 loss in FY 2023)Full year 2024 results: NT$1.23 loss per share (improved from NT$1.87 loss in FY 2023). Revenue: NT$61.5m (down 4.9% from FY 2023). Net loss: NT$48.1m (loss narrowed 26% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 33% per year, which means it is well ahead of earnings.New Risk • Mar 11New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 8.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.0% average weekly change). Earnings have declined by 34% per year over the past 5 years. Minor Risks Revenue is less than US$5m (NT$68m revenue, or US$2.1m). Market cap is less than US$100m (NT$1.56b market cap, or US$47.5m).お知らせ • Mar 07NeoCore Technology Co., Ltd., Annual General Meeting, Jun 26, 2025NeoCore Technology Co., Ltd., Annual General Meeting, Jun 26, 2025. Location: no,31, k`o chung, jhunan township, miaoli county TaiwanNew Risk • Dec 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 34% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.4% average weekly change). Revenue is less than US$5m (NT$68m revenue, or US$2.1m). Market cap is less than US$100m (NT$1.30b market cap, or US$40.1m).Reported Earnings • Nov 18Third quarter 2024 earnings released: NT$0.36 loss per share (vs NT$0.50 loss in 3Q 2023)Third quarter 2024 results: NT$0.36 loss per share (improved from NT$0.50 loss in 3Q 2023). Revenue: NT$16.5m (up 18% from 3Q 2023). Net loss: NT$14.0m (loss narrowed 28% from 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings.Reported Earnings • Aug 17Second quarter 2024 earnings released: NT$0.39 loss per share (vs NT$0.39 loss in 2Q 2023)Second quarter 2024 results: NT$0.39 loss per share (in line with 2Q 2023). Revenue: NT$17.7m (up 40% from 2Q 2023). Net loss: NT$15.1m (flat on 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 30% per year, which means it is well ahead of earnings.New Risk • Jul 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 27% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.6% average weekly change). Revenue is less than US$5m (NT$61m revenue, or US$1.9m). Market cap is less than US$100m (NT$1.33b market cap, or US$40.8m).Reported Earnings • May 20First quarter 2024 earnings released: NT$0.40 loss per share (vs NT$0.45 loss in 1Q 2023)First quarter 2024 results: NT$0.40 loss per share. Revenue: NT$15.8m (down 20% from 1Q 2023). Net loss: NT$15.6m (loss widened 63% from 1Q 2023).お知らせ • Apr 11NeoCore Technology Co., Ltd., Annual General Meeting, Jun 25, 2024NeoCore Technology Co., Ltd., Annual General Meeting, Jun 25, 2024.Reported Earnings • Mar 20Full year 2023 earnings released: NT$1.87 loss per share (vs NT$1.49 loss in FY 2022)Full year 2023 results: NT$1.87 loss per share (further deteriorated from NT$1.49 loss in FY 2022). Revenue: NT$64.7m (down 27% from FY 2022). Net loss: NT$64.6m (loss widened 129% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 25% per year, which means it is well ahead of earnings.New Risk • Dec 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 5.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (105% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (5.9% average weekly change). Revenue is less than US$5m (NT$74m revenue, or US$2.3m). Market cap is less than US$100m (NT$895.1m market cap, or US$28.4m).Reported Earnings • Aug 11Second quarter 2023 earnings released: NT$0.39 loss per share (vs NT$0.52 loss in 2Q 2022)Second quarter 2023 results: NT$0.39 loss per share. Revenue: NT$12.7m (up 10.0% from 2Q 2022). Net loss: NT$15.2m (loss widened 53% from 2Q 2022).Reported Earnings • Mar 31Full year 2022 earnings released: NT$1.49 loss per share (vs NT$0.91 loss in FY 2021)Full year 2022 results: NT$1.49 loss per share (further deteriorated from NT$0.91 loss in FY 2021). Revenue: NT$89.0m (flat on FY 2021). Net loss: NT$28.2m (loss widened 64% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 28% per year, which means it is well ahead of earnings.Reported Earnings • Nov 19Third quarter 2022 earnings released: NT$0.44 loss per share (vs NT$0.23 loss in 3Q 2021)Third quarter 2022 results: NT$0.44 loss per share (further deteriorated from NT$0.23 loss in 3Q 2021). Revenue: NT$21.1m (up 14% from 3Q 2021). Net loss: NT$8.28m (loss widened 86% from 3Q 2021). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.Reported Earnings • Aug 18Second quarter 2022 earnings released: NT$0.52 loss per share (vs NT$0.19 loss in 2Q 2021)Second quarter 2022 results: NT$0.52 loss per share (down from NT$0.19 loss in 2Q 2021). Revenue: NT$11.5m (down 40% from 2Q 2021). Net loss: NT$9.94m (loss widened 171% from 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.Reported Earnings • May 11First quarter 2022 earnings released: NT$0.21 loss per share (vs NT$0.13 loss in 1Q 2021)First quarter 2022 results: NT$0.21 loss per share (down from NT$0.13 loss in 1Q 2021). Revenue: NT$28.8m (up 15% from 1Q 2021). Net loss: NT$3.94m (loss widened 56% from 1Q 2021). Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 3% per year.Reported Earnings • Nov 13Third quarter 2021 earnings released: NT$0.09 loss per share (vs NT$0.097 loss in 3Q 2020)The company reported a soft third quarter result with weaker revenues and control over costs, although losses reduced. Third quarter 2021 results: Revenue: NT$18.4m (down 29% from 3Q 2020). Net loss: NT$4.44m (loss narrowed 5.6% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 09Second quarter 2021 earnings released: NT$0.08 loss per share (vs NT$0.12 loss in 2Q 2020)The company reported a decent second quarter result with reduced losses and improved control over expenses, although revenues were weaker. Second quarter 2021 results: Revenue: NT$19.3m (down 15% from 2Q 2020). Net loss: NT$3.66m (loss narrowed 36% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.Reported Earnings • May 16First quarter 2021 earnings released: NT$0.05 loss per share (vs NT$0.20 loss in 1Q 2020)The company reported a solid first quarter result with reduced losses, improved revenues and improved control over expenses. First quarter 2021 results: Revenue: NT$25.0m (up 18% from 1Q 2020). Net loss: NT$2.53m (loss narrowed 74% from 1Q 2020). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.分析記事 • Apr 19DR.Chip Biotechnology Incorporation (GTSM:4131) Is Carrying A Fair Bit Of DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Reported Earnings • Mar 19Full year 2020 earnings released: NT$0.56 loss per share (vs NT$0.25 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: NT$93.3m (down 11% from FY 2019). Net loss: NT$27.1m (loss widened 128% from FY 2019). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.お知らせ • Mar 09DR.Chip Biotechnology Incorporation, Annual General Meeting, Jun 15, 2021DR.Chip Biotechnology Incorporation, Annual General Meeting, Jun 15, 2021.Is New 90 Day High Low • Mar 05New 90-day high: NT$7.65The company is up 4.0% from its price of NT$7.34 on 04 December 2020. The Taiwanese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is up 9.0% over the same period.Is New 90 Day High Low • Jan 25New 90-day low: NT$5.15The company is down 34% from its price of NT$7.80 on 28 October 2020. The Taiwanese market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 1.0% over the same period.Is New 90 Day High Low • Jan 06New 90-day low: NT$6.13The company is down 35% from its price of NT$9.45 on 08 October 2020. The Taiwanese market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 3.0% over the same period.分析記事 • Jan 04DR.Chip Biotechnology Incorporation (GTSM:4131) Is Carrying A Fair Bit Of DebtThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Is New 90 Day High Low • Dec 08New 90-day low: NT$7.00The company is down 35% from its price of NT$10.75 on 09 September 2020. The Taiwanese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 5.0% over the same period.Is New 90 Day High Low • Nov 17New 90-day low: NT$7.27The company is down 29% from its price of NT$10.20 on 19 August 2020. The Taiwanese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 5.0% over the same period.Reported Earnings • Nov 10Third quarter 2020 earnings released: NT$0.09 loss per shareThe company reported a poor third quarter result with weaker earnings and control over expenses, although revenues were flat. Third quarter 2020 results: Revenue: NT$25.9m (flat on 3Q 2019). Net loss: NT$4.70m (down 280% from profit in 3Q 2019). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.Is New 90 Day High Low • Oct 28New 90-day low: NT$7.80The company is down 22% from its price of NT$10.00 on 30 July 2020. The Taiwanese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 7.0% over the same period.Is New 90 Day High Low • Sep 30New 90-day low: NT$7.87The company is down 16% from its price of NT$9.41 on 02 July 2020. The Taiwanese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 9.0% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、NeoCore Technology は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測TPEX:4131 - アナリストの将来予測と過去の財務データ ( )TWD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/2026236-20-103-54N/A12/31/2025245-31-26-21N/A9/30/2025190-20-23-18N/A6/30/2025151-18-18-10N/A3/31/2025115-45-32-20N/A12/31/202462-48-70-57N/A9/30/202468-65-71-59N/A6/30/202466-71-77-65N/A3/31/202461-71-85-73N/A12/31/202365-65-75-64N/A9/30/202374-50-67-55N/A6/30/202381-39-46-39N/A3/31/202380-34-27-25N/A12/31/202289-28-3-3N/A9/30/202288-29-5-5N/A6/30/202285-25-8-8N/A3/31/202293-19-7-7N/A12/31/202189-17-17-17N/A9/30/202186-18-26-26N/A6/30/202194-18-22-22N/A3/31/202197-20-25-25N/A12/31/202093-27-28-28N/A9/30/202096-28-21-20N/A6/30/202097-20-13-13N/A3/31/202097-18-9-8N/A12/31/2019104-12N/A-4N/A9/30/201999-12N/A-10N/A6/30/2019100-21N/A-22N/A3/31/201987-24N/A-34N/A12/31/201862-25N/A-28N/A9/30/201842-22N/A-22N/A6/30/201818-22N/A-21N/A3/31/201812-22N/A10N/A12/31/201712-21N/A37N/A9/30/201714-25N/A44N/A6/30/201716-27N/A19N/A3/31/201716-28N/A-11N/A12/31/201617-28N/A-24N/A9/30/201618-20N/A47N/A6/30/201619-17N/A49N/A3/31/201620-18N/A63N/A12/31/201522-17N/A53N/A9/30/201526-19N/A17N/A6/30/201526-22N/A12N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 4131の予測収益成長が 貯蓄率 ( 1.3% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 4131の収益がTW市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 4131の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 4131の収益がTW市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 4131の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 4131の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 12:59終値2026/05/22 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋NeoCore Technology Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • May 14First quarter 2026 earnings released: NT$0.046 loss per share (vs NT$0.32 loss in 1Q 2025)First quarter 2026 results: NT$0.046 loss per share (improved from NT$0.32 loss in 1Q 2025). Revenue: NT$60.5m (down 13% from 1Q 2025). Net loss: NT$1.82m (loss narrowed 85% from 1Q 2025). Over the last 3 years on average, earnings per share has increased by 38% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 14Full year 2025 earnings released: NT$1.23 loss per share (vs NT$1.23 loss in FY 2024)Full year 2025 results: NT$1.23 loss per share (improved from NT$1.23 loss in FY 2024). Revenue: NT$61.5m (flat on FY 2024). Net loss: NT$48.1m (flat on FY 2024). Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.
お知らせ • Mar 05NeoCore Technology Co., Ltd., Annual General Meeting, Jun 24, 2026NeoCore Technology Co., Ltd., Annual General Meeting, Jun 24, 2026. Location: no,9, lu k`o 1st rd., lujhu district, kaohsiung city Taiwan
Reported Earnings • Nov 15Third quarter 2025 earnings released: NT$0.42 loss per share (vs NT$0.36 loss in 3Q 2024)Third quarter 2025 results: NT$0.42 loss per share (further deteriorated from NT$0.36 loss in 3Q 2024). Revenue: NT$55.2m (up 235% from 3Q 2024). Net loss: NT$16.7m (loss widened 19% from 3Q 2024). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 17Second quarter 2025 earnings released: EPS: NT$0.31 (vs NT$0.39 loss in 2Q 2024)Second quarter 2025 results: EPS: NT$0.31 (up from NT$0.39 loss in 2Q 2024). Revenue: NT$53.7m (up 204% from 2Q 2024). Net income: NT$12.0m (up NT$27.1m from 2Q 2024). Profit margin: 22% (up from net loss in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 10% per year but the company’s share price has increased by 18% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • May 14First quarter 2025 earnings released: NT$0.31 loss per share (vs NT$0.40 loss in 1Q 2024)First quarter 2025 results: NT$0.31 loss per share (improved from NT$0.40 loss in 1Q 2024). Revenue: NT$69.6m (up 341% from 1Q 2024). Net loss: NT$12.3m (loss narrowed 21% from 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 35% per year, which means it is well ahead of earnings.
Reported Earnings • Mar 19Full year 2024 earnings released: NT$1.23 loss per share (vs NT$1.87 loss in FY 2023)Full year 2024 results: NT$1.23 loss per share (improved from NT$1.87 loss in FY 2023). Revenue: NT$61.5m (down 4.9% from FY 2023). Net loss: NT$48.1m (loss narrowed 26% from FY 2023). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 33% per year, which means it is well ahead of earnings.
New Risk • Mar 11New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 8.0% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (8.0% average weekly change). Earnings have declined by 34% per year over the past 5 years. Minor Risks Revenue is less than US$5m (NT$68m revenue, or US$2.1m). Market cap is less than US$100m (NT$1.56b market cap, or US$47.5m).
お知らせ • Mar 07NeoCore Technology Co., Ltd., Annual General Meeting, Jun 26, 2025NeoCore Technology Co., Ltd., Annual General Meeting, Jun 26, 2025. Location: no,31, k`o chung, jhunan township, miaoli county Taiwan
New Risk • Dec 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 34% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.4% average weekly change). Revenue is less than US$5m (NT$68m revenue, or US$2.1m). Market cap is less than US$100m (NT$1.30b market cap, or US$40.1m).
Reported Earnings • Nov 18Third quarter 2024 earnings released: NT$0.36 loss per share (vs NT$0.50 loss in 3Q 2023)Third quarter 2024 results: NT$0.36 loss per share (improved from NT$0.50 loss in 3Q 2023). Revenue: NT$16.5m (up 18% from 3Q 2023). Net loss: NT$14.0m (loss narrowed 28% from 3Q 2023). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 22% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 17Second quarter 2024 earnings released: NT$0.39 loss per share (vs NT$0.39 loss in 2Q 2023)Second quarter 2024 results: NT$0.39 loss per share (in line with 2Q 2023). Revenue: NT$17.7m (up 40% from 2Q 2023). Net loss: NT$15.1m (flat on 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 30% per year, which means it is well ahead of earnings.
New Risk • Jul 18New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 27% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.6% average weekly change). Revenue is less than US$5m (NT$61m revenue, or US$1.9m). Market cap is less than US$100m (NT$1.33b market cap, or US$40.8m).
Reported Earnings • May 20First quarter 2024 earnings released: NT$0.40 loss per share (vs NT$0.45 loss in 1Q 2023)First quarter 2024 results: NT$0.40 loss per share. Revenue: NT$15.8m (down 20% from 1Q 2023). Net loss: NT$15.6m (loss widened 63% from 1Q 2023).
お知らせ • Apr 11NeoCore Technology Co., Ltd., Annual General Meeting, Jun 25, 2024NeoCore Technology Co., Ltd., Annual General Meeting, Jun 25, 2024.
Reported Earnings • Mar 20Full year 2023 earnings released: NT$1.87 loss per share (vs NT$1.49 loss in FY 2022)Full year 2023 results: NT$1.87 loss per share (further deteriorated from NT$1.49 loss in FY 2022). Revenue: NT$64.7m (down 27% from FY 2022). Net loss: NT$64.6m (loss widened 129% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 25% per year, which means it is well ahead of earnings.
New Risk • Dec 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 5.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 14% per year over the past 5 years. Shareholders have been substantially diluted in the past year (105% increase in shares outstanding). Minor Risks Share price has been volatile over the past 3 months (5.9% average weekly change). Revenue is less than US$5m (NT$74m revenue, or US$2.3m). Market cap is less than US$100m (NT$895.1m market cap, or US$28.4m).
Reported Earnings • Aug 11Second quarter 2023 earnings released: NT$0.39 loss per share (vs NT$0.52 loss in 2Q 2022)Second quarter 2023 results: NT$0.39 loss per share. Revenue: NT$12.7m (up 10.0% from 2Q 2022). Net loss: NT$15.2m (loss widened 53% from 2Q 2022).
Reported Earnings • Mar 31Full year 2022 earnings released: NT$1.49 loss per share (vs NT$0.91 loss in FY 2021)Full year 2022 results: NT$1.49 loss per share (further deteriorated from NT$0.91 loss in FY 2021). Revenue: NT$89.0m (flat on FY 2021). Net loss: NT$28.2m (loss widened 64% from FY 2021). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 28% per year, which means it is well ahead of earnings.
Reported Earnings • Nov 19Third quarter 2022 earnings released: NT$0.44 loss per share (vs NT$0.23 loss in 3Q 2021)Third quarter 2022 results: NT$0.44 loss per share (further deteriorated from NT$0.23 loss in 3Q 2021). Revenue: NT$21.1m (up 14% from 3Q 2021). Net loss: NT$8.28m (loss widened 86% from 3Q 2021). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 18Second quarter 2022 earnings released: NT$0.52 loss per share (vs NT$0.19 loss in 2Q 2021)Second quarter 2022 results: NT$0.52 loss per share (down from NT$0.19 loss in 2Q 2021). Revenue: NT$11.5m (down 40% from 2Q 2021). Net loss: NT$9.94m (loss widened 171% from 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 45% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.
Reported Earnings • May 11First quarter 2022 earnings released: NT$0.21 loss per share (vs NT$0.13 loss in 1Q 2021)First quarter 2022 results: NT$0.21 loss per share (down from NT$0.13 loss in 1Q 2021). Revenue: NT$28.8m (up 15% from 1Q 2021). Net loss: NT$3.94m (loss widened 56% from 1Q 2021). Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 3% per year.
Reported Earnings • Nov 13Third quarter 2021 earnings released: NT$0.09 loss per share (vs NT$0.097 loss in 3Q 2020)The company reported a soft third quarter result with weaker revenues and control over costs, although losses reduced. Third quarter 2021 results: Revenue: NT$18.4m (down 29% from 3Q 2020). Net loss: NT$4.44m (loss narrowed 5.6% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 09Second quarter 2021 earnings released: NT$0.08 loss per share (vs NT$0.12 loss in 2Q 2020)The company reported a decent second quarter result with reduced losses and improved control over expenses, although revenues were weaker. Second quarter 2021 results: Revenue: NT$19.3m (down 15% from 2Q 2020). Net loss: NT$3.66m (loss narrowed 36% from 2Q 2020). Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
Reported Earnings • May 16First quarter 2021 earnings released: NT$0.05 loss per share (vs NT$0.20 loss in 1Q 2020)The company reported a solid first quarter result with reduced losses, improved revenues and improved control over expenses. First quarter 2021 results: Revenue: NT$25.0m (up 18% from 1Q 2020). Net loss: NT$2.53m (loss narrowed 74% from 1Q 2020). Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has fallen by 3% per year, which means it is significantly lagging earnings.
分析記事 • Apr 19DR.Chip Biotechnology Incorporation (GTSM:4131) Is Carrying A Fair Bit Of DebtDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Reported Earnings • Mar 19Full year 2020 earnings released: NT$0.56 loss per share (vs NT$0.25 loss in FY 2019)The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2020 results: Revenue: NT$93.3m (down 11% from FY 2019). Net loss: NT$27.1m (loss widened 128% from FY 2019). Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
お知らせ • Mar 09DR.Chip Biotechnology Incorporation, Annual General Meeting, Jun 15, 2021DR.Chip Biotechnology Incorporation, Annual General Meeting, Jun 15, 2021.
Is New 90 Day High Low • Mar 05New 90-day high: NT$7.65The company is up 4.0% from its price of NT$7.34 on 04 December 2020. The Taiwanese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is up 9.0% over the same period.
Is New 90 Day High Low • Jan 25New 90-day low: NT$5.15The company is down 34% from its price of NT$7.80 on 28 October 2020. The Taiwanese market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 1.0% over the same period.
Is New 90 Day High Low • Jan 06New 90-day low: NT$6.13The company is down 35% from its price of NT$9.45 on 08 October 2020. The Taiwanese market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 3.0% over the same period.
分析記事 • Jan 04DR.Chip Biotechnology Incorporation (GTSM:4131) Is Carrying A Fair Bit Of DebtThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Is New 90 Day High Low • Dec 08New 90-day low: NT$7.00The company is down 35% from its price of NT$10.75 on 09 September 2020. The Taiwanese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 5.0% over the same period.
Is New 90 Day High Low • Nov 17New 90-day low: NT$7.27The company is down 29% from its price of NT$10.20 on 19 August 2020. The Taiwanese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 5.0% over the same period.
Reported Earnings • Nov 10Third quarter 2020 earnings released: NT$0.09 loss per shareThe company reported a poor third quarter result with weaker earnings and control over expenses, although revenues were flat. Third quarter 2020 results: Revenue: NT$25.9m (flat on 3Q 2019). Net loss: NT$4.70m (down 280% from profit in 3Q 2019). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
Is New 90 Day High Low • Oct 28New 90-day low: NT$7.80The company is down 22% from its price of NT$10.00 on 30 July 2020. The Taiwanese market is up 3.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 7.0% over the same period.
Is New 90 Day High Low • Sep 30New 90-day low: NT$7.87The company is down 16% from its price of NT$9.41 on 02 July 2020. The Taiwanese market is up 6.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Biotechs industry, which is down 9.0% over the same period.